Hemophilia Inhibitors
According to hemophiliafed.org approximately 30% of people with severe hemophilia A are affected by inhibitors at some point in their lives. An inhibitor usually occurs between the 5th and 50th infusion of factor concentrate, but in rare cases can also be developed later in life.
This can be challenging because inhibitors can create more problems like joint arthropathy, which adds to the overall cost of hemophilia.
Sheh-Li Chen, PharmD, BCOP research the economic costs of hemophilia and how that impacts treatment and reported that, “costs rise substantially for patients with complications, such as HIV seropositivity, arthropathy, and/or development of inhibitors. Some estimates claim treatment costs as high as $1 million per year for these patients.”
HF Healthcare provides all of the products used to treat inhibitors and can create a manageable care plan that works in concert with your physician and insurance payer. We are here to guide you to a healthy future!